Rosenblatt Maintains Buy on Imax, Raises Price Target to $50
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $47 to $50.
Rosenblatt analyst Steve Frankel maintains Imax (NYSE:IMAX) with a Buy and raises the price target from $47 to $50.